In 2012, new technologies accounted for 31.7% of the market and are forecast to rise to 36.8% by 2017. Of the older technologies, sutures will be most affected, falling from a market share of 48.8% in 2012 to 45% in 2017.
Dallas, Texas (PRWEB) September 21, 2013
The principal drivers of advanced wound closure market growth are the rising numbers of surgical procedures being performed globally and the increasing adoption of advanced biosurgery products such as surgical sealants and haemostats by clinicians. There is a geographical twist, with higher demand in emerging economies for lower-cost traditional wound closure products, while newer technologies are finding more favourable conditions in western markets, principally the US. Despite these positives, the sector faces challenges. The weak global economy and health payer cost control policies have impacted healthcare spending. In such a market, healthcare providers are not always inclined to sanction advanced products over lower-cost treatments.
Advanced biosurgery products set to lead market growth says the report Opportunities in Advanced Wound Closure available at http://www.marketreportsonline.com/274335.html:
While traditional wound closure products will continue to dominate the market, it is the new sectors that will see the best growth. Wider adoption of surgical sealants and haemostat technologies outside of the US will see these new approaches maintain annual growth rates of up to 7% over the next 5 years. In 2012, new technologies accounted for 31.7% of the market and are forecast to rise to 36.8% by 2017. Of the older technologies, sutures will be most affected, falling from a market share of 48.8% in 2012 to 45% in 2017. These figures must been seen in the context of the whole wound closure market: from an annual growth of 3.1% in 2012 we forecast that growth will rise over 5 years to 4.5% in 2017.
Competitive Landscape: For some years, J&J’s Ethicon has been the market leader due its dominating position in the sutures market. However, the company is facing stiffer opposition in the biosurgery sector. For example, market-leading surgical sealants such as Baxter’s Coseal, CryoLife's BioGlue, Covidien's DuraSeal and CR Bard's NeoMend are competing with Ethicon's OMNEX. A number of new companies have entered the field attracted by the wound closure sector’s positive market attributes and growth potential.
The report Opportunities in Advanced Wound Closure, available for purchase at http://www.marketreportsonline.com/contacts/purchase.php?name=274335, covers all major wound closure technologies:
- Staples and Clips
- Topical Skin Adhesives
- Fibrin Sealants and Thrombin Products
- Internal Surgical Sealants
- Surgical Haemostats and Haemostatic Bandages
List of Tables
Summary: Methods of Wound Closure .4
Key Wound Closure Mergers and Acquisitions, 2011-2013 .9
Global Wound Closure Market by Product Type, 2008-2012 (US$ million) . .11
Growth in the Global Wound Closure Market by Product Type, 2009-2012 (%) .11
Summary: US & EU Wound Closure Regulatory Environment .12
Summary: Market Drivers, Restraints and Opportunities .14
Synthetic Surgical Sealants Currently on the Market .18
CryoLife’s Surgical Sealant Sales by Region, 2011-2012 (US$ thousands) .20
Fibrin Sealants Currently on the Market .30
Haemostatic Agents Currently on the Market .36
Products Currently on the Market .51
Topical Tissue Adhesives: Benefits and Disadvantages .56
List of Charts available in the market report Opportunities in Advanced Wound Closure:
Fig .1: Wound Closure Market Shares by Competitor, 2012 . .6
Fig .2: Sutures Market Shares by Competitor, 2012 .6
Fig .3: Wound Closure Market by Product Type, 2012 .11
Fig .4: Wound Closure Market by Geographic Region, 2012 .13
Fig .6: Surgical Sealants Market, 2008-2017E (US$ million) .16
Fig .7: Surgical Sealants Market Growth, 2009-2017E (%) .16
Fig .8: Surgical Sealants Market by Geographic Region, 2012 . .17
Fig .9: CryoLife’s Surgical Sealant Sales, 2008-2012 (US$ thousands) .20
Fig .10: CryoLife’s Surgical Sealant Sales by Product, 2012 .21
Fig .11: CryoLife’s Surgical Sealant Sales by Geographic Region, 2012 .21
Fig .12: Haemostatic Agents Market, 2008-2017E (US$ million) .35
Fig .13: Haemostatic Agents Market Growth, 2009-2017E (%) .35
Fig .14: Haemostatic Agents Market by Geographic Region, 2012 . .36
Fig .15: CryoLife’s PerClot Revenue, 2010-2012 (US$ thousands) .44
Fig .16: Topical Tissue Adhesive Market, 2008-2017E (US$ millions) .57
Fig .17: Topical Tissue Adhesive Market, 2009-2017E (%) . .58
Fig .18: Topical Tissue Adhesive Market by Geographic Region, 2012 .58
Explore more reports on Medical Devices market at http://www.marketreportsonline.com/cat/medical-devices-market-research.html and on the wound care market at http://www.marketreportsonline.com/industry/wound-care-market-research.html .
MarketReportsOnline.com is an online database of regional industry research reports, company profiles and SWOT analysis studies for multiple industries and organizations. Our sales and research experts offer 24 X 7 support to our customers through phone and email communication. Not limited to the life sciences industry, MarketReportsOnline.com offers research studies on agriculture, chemicals, energy, power, environment, food and beverages, healthcare, medical devices and much more.